Alternatives to Conventional Antibiotic Therapy: Potential Therapeutic Strategies of Combating Antimicrobial-Resistance and Biofilm-Related Infections

Molecular biotechnology · 2021 · vol. 63(12) , pp. 1103–1124 · doi:10.1007/s12033-021-00371-2 · PMID:34309796
Review OA: closed
View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-02 ⓘ

This review discusses alternative therapeutic strategies, including nanoparticles and phage therapy, to combat antimicrobial resistance and biofilm-related infections.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Antibiotics have been denoted as the orthodox therapeutic agents for fighting bacteria-related infections in clinical practices for decades. Nevertheless, overuse of antibiotics has led to the upsurge of species with antimicrobial resistance (AMR) or multi-drug resistance. Bacteria can also grow into the biofilm, which accounts for at least two-thirds of infections. Distinct gene expression and self-produced heterogeneous hydrated extracellular polymeric substance matrix architecture of biofilm contribute to their tolerance and externally manifest as antibiotic resistance. In this review, the difficulties in combating biofilm formation and AMR are introduced, and novel alternatives to antibiotics such as metal nanoparticles and quaternary ammonium compounds, chitosan and its derivatives, antimicrobial peptides, stimuli-responsive materials, phage therapy and other therapeutic strategies, from compounds to hydrogel, from inorganic to biological, are discussed. We expect to provide useful information for the readers who are seeking for solutions to the problem of AMR and biofilm-related infections.

My notes (saved in your browser only)

MeSH descriptors

Anti-Bacterial Agents Bacteria Bacterial Infections Extracellular Polymeric Substance Matrix Anti-Bacterial Agents Anti-Bacterial Agents Antimicrobial Peptides Antimicrobial Peptides Antimicrobial Peptides Bacteria Bacteria Bacterial Infections Bacterial Infections Biofilms Biofilms Drug Resistance, Bacterial Drug Resistance, Bacterial Extracellular Polymeric Substance Matrix Extracellular Polymeric Substance Matrix Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:31:51.421232+00:00
unpaywall
last seen: 2026-10-27T06:37:41.825712+00:00